Tumor-associated fibroblasts (Part I): Active stromal participants in tumor development and progression?

Histology and Histopathology

Volumn 17, Issue 2, 2002, Pages 599-621

  Kunz Schughart, Leoni A ^a   Knuechel, R ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Cell adhesion molecules; Chemokines; Cytokines; Desmoplasia; Fibroblast; Growth factors; Integrins; Matrix metalloproteinases; Multicellular spheroid; Myofibroblast; Oncofetal extracellular matrix

Indexed keywords

ALPHA ACTIN; AUTOCRINE MOTILITY FACTOR; CADHERIN; CATENIN; CATHEPSIN B; CELL ADHESION MOLECULE; CHEMOKINE; COLLAGEN TYPE 5; CYTOKERATIN 18; CYTOKINE; DESMIN; FIBRONECTIN; GELATINASE A; GROWTH FACTOR; INTEGRIN; INTERLEUKIN 4; LAMININ; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MIGRATION STIMULATING FACTOR; PLATELET DERIVED GROWTH FACTOR; PROTEOGLYCAN; SERINE PROTEINASE; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; THROMBOSPONDIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA; UNINDEXED DRUG; VIMENTIN;

CELL INTERACTION; DISEASE COURSE; FETUS CELL; FIBROBLAST; FIBROMA; GENOTYPE; HUMAN; IMMUNOHISTOCHEMISTRY; MULTICELLULAR SPHEROID; MYOFIBROBLAST; NOMENCLATURE; PHENOTYPE; REVIEW; SMOOTH MUSCLE; STROMA; TUMOR CELL; TUMOR GROWTH;

ANIMALS; DISEASE PROGRESSION; FIBROBLASTS; GENOTYPE; HUMANS; NEOPLASMS; PHENOTYPE;

EID: 0036113238     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (277)

1. Pathology and prognosis of gastric carcinoma: Well versus poorly differentiated type
2. The alpha v beta 6 integrin induces getatinase B secretion in colon cancer cells
3. Role for CD40-CD40 ligand interactions in the immune response to solid tumours
4. Increased sensitivity of tumor-bearing host macrophages to interleukin-10: A counter-balancing action to macrophage-mediated suppression
5. Cytokine regulation of chemokine (IL-8, MCP-1, and RANTES) gene expression in human pancreatic periacinar myofibroblasts
6. Stromal expression of fibroblast activation protein/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breast
7. Extracellular cysteine proteinase and collagenase activities as a consequence of tumor-host interaction in the rabbit V2 carcinoma
8. Tumor-host interactions in the rabbit V2 carcinoma: Stimulation of cathepsin B in host fibroblasts by a tumor-derived cytokine
9. Expression of adhesion molecules in the host response to colon carcinoma
10. Desmoplastic breast carcinoma as a source of human myofibroblasts
11. Expression of the stromelysin-3 gene in fibroblastic cells of invasive carcinomas of the breast and other human tissues: A review
12. A method for three-dimensional coculture of cancer cells combined to any other type of cells maintained organotypically
13. Appearance of the myofibroblastic phenotype in Dupuytren's disease is associated with a fibronectin, laminin, collagen type IV and tenascin extracellular matrix
14. TGF beta and bFGF synthesis and localization in Dupuytren's disease (nodular palmar fibromatosis) relative to cellular activity, myofibroblast phenotype and oncofetal variants of fibronectin
15. Oral squamous cell carcinoma invasion is associated with a laminin-5 matrix re-organization but independent of basement membrane and hemidesmosome formation, clues from an in vitro invasion model
16. Thrombospondin-1 and -2 messenger RNA expression in normal, benign, and neoplastic human breast tissues: Correlation with prognostic factors, tumor angiogenesis, and fibroblastic desmoplasia
17. Immunohistochemical localization of the plasminogen activator inhibitor-1 in breast cancer
18. Epithelial-mesenchymal transitions in cancer progression
19. Tissue structure, nuclear organization, and gene expression in normal and malignant breast
20. Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas
21. Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions
22. Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas
23. Fibroblast-directed expression and localization of 92-kDa type IV collagenase along the tumor-stroma interface in an in vitro three-dimensional model of human squamous cell carcinoma
24. Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI-1)
25. MMP-2 release and activation in ovarian carcinoma: The role of fibroblasts
26. Variable beta-catenin expression in colorectal cancers indicates a tumor progression driven by the tumor environment
27. Angiogenesis and cancer control: From concept to therapeutic trial
28. Desmoplastic squamous cell carcinoma of skin and vermilion surface: A highly malignant subtype of skin cancer
29. Myofibroblast and concurrent ED-B fibronectin phenotype in human stromal cells cultured from non-malignant and malignant breast tissue
30. Fetal myofibroblast-like cells isolated from post-radiation fibrosis in human breast cancer
31. Chemokines and CD40 expression in human fibroblasts
32. Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart
33. Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival
34. Angiogenesis in cancer and other diseases
35. Immunohistochemical analysis of cathepsins D, B, and L in human breast cancer
36. Expression of the extracellular matrix metalloproteinase inducer (EMMPRIN) and the matrix metalloproteinase-2 in bronchopulmonary and breast lesions
37. Presence of high levels of MT1-MMP protein in fibroblastic cells of human invasive carcinomas
38. New paradigms for the treatment of cancer: The role of anti-angiogenesis agents
39. Expression of myosin heavy chain isoforms in mammary epithelial cells and in myofibroblasts from different fibrotic settings during neoplasia
40. Tenascin and other adhesion-modulating proteins in cancer
41. Tenascin: An extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis
42. Participation of tenascin and transforming growth factor-beta in reciprocal epithelial-mesenchymal interactions of MCF7 cells and fibroblasts
43. Cellular activation through the ligation of intercellular adhesion molecule-1
44. Form and function: The laminin family of heterotrimers
45. Matrix metalloproteinases in tumour invasion and metastasis
46. Matrix metalloproteinases, molecular aspects of their roles in tumour invasion and metastasis
47. Changes in the expression of syndecan-1 in the colorectal adenoma-carcinoma sequence
48. The origin of hyaluronectin in human tumors
49. Factors influencing myofibroblast differentiation during wound healing and fibrosis
50. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts
51. The cancer cell and the connective tissue. A historical retrospect
52. In vivo and in vitro invasiveness of a rat colon-cancer cell line maintaining E-cadherin expression: An enhancing role of tumor-associated myofibroblasts
53. Extracellular matrix, integrin and focal adhesions
54. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing
55. Tumour vasculature as a target for anticancer therapy
56. Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-beta1 and TGF-beta3
57. Stimulation of tenascin expression in mesenchyme by epithelial-mesenchymal interactions
58. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation
59. Tumor-induced immune dysfunction: The macrophage connection
60. Membrane associated matrix metalloproteinases in metastasis
61. Differential response of fetal and adult fibroblasts to cytokines: Cell migration and hyaluronan synthesis
62. Antagonistic effects of TGF-beta 1 and MSF on fibroblast migration and hyaluronic acid synthesis. Possible implications for dermal wound healing
63. Insulin-like growth factor mediated stromal-epithelial interactions in human breast cancer
64. Tenascin: An extracellular matrix protein prominent in specialized embryonic tissues and tumors
65. Tenascin distribution in the normal human breast is altered during the menstrual cycle and in carcinoma
66. Myofibroblastic tumours: An update
67. Angiogenesis and angiogenesis inhibition: An overview
68. Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures
69. Matrix metalloproteinases as insulin-like growth factor binding protein-degrading proteinases
70. The cellular derivation and the life span of the myofibroblast
71. Some historical and philosophical reflections on the myofibroblast concept
72. The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer
73. Transforming growth factor-beta initiates wound repair in rat liver through induction of the EIIIA-fibronectin splice isoform
74. Costimulation of fibroblast collagen and transforming growth factor beta1 gene expression by monocyte chemoattractant protein-1 via specific receptors
75. The c-ets-1 proto-oncogene is a new early-response gene differentially regulated by cytokines and growth factors in human fibroblasts
76. Expression of leucocyte chemoattractants by interstitial renal fibroblasts: Up-regulation by drugs associated with interstitial fibrosis
77. Histochemical localization of cathepsin B at the invasion front of the rabbit V2 carcinoma
78. The role of fibroblasts in tumor behavior
79. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis
80. Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells
81. Association between invasiveness, inflammatory reaction, desmoplasia and survival in colorectal cancer
82. Expression of alpha(v)beta6 integrin in oral leukoplakia
83. Tissue architecture and breast cancer: The role of extracellular matrix and steroid hormones
84. New prognostic histological parameter of invasive ductal carcinoma of the breast: Clinicopathological significance of fibrotic focus
85. Proliferative activity of intratumoral fibroblasts is closely correlated with lymph node and distant organ metastases of invasive ductal carcinoma of the breast
86. Cytoskeletal characteristics of myofibroblasts in benign neoplastic and reactive fibroblastic lesions
87. An oveview of epithelio-mesenchymal transformation
88. Genetic and epigenetic influences in prostatic carcinogenesis
89. Mechanism of action and in vivo role of platelet-derived growth factor
90. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host responses
91. CD44 acts both as a growth and invasiveness-promoting molecule and as a tumor-suppressing cofactor
92. Induction of tenascin in cancer cells by interactions with embryonic mesenchyme mediated by a diffusible factor
93. Differential monocyte chemoattractant protein-1 and chemokine receptor 2 expression by murine lung fibroblasts derived from Th1- and Th2-type pulmonary granuloma models
94. Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast
95. The insulin-like growth factor-binding protein(IGFBP) superfamily
96. Expression of tenascin in gastric carcinoma
97. Expression of membrane-type matrix metalloproteinase-1 in human pancreatic adenocarcinomas
98. The role of syndecan-1 in malignancies
99. Localization of oncofetal and normal fibronectin in colorectal cancer. Correlation with histologic grade, liver metastasis, and prognosis
100. Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance
101. Expression of tenascin-C in intraductal carcinoma of human breast: Relationship to invasion
102. Tenascin-C expression in invasion border of early breast cancer: A predictor of local and distant recurrence
103. Prognostic value of clinicopoathological parameters in head and neck squamous cell carcinoma: A prospective analysis
104. Changes in the expression of alpha v integrins in oral squamous cell carcinomas
105. Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissues
106. The significance of stromal desmoplasia in intrahepatic cholangiocarcinoma: A special reference of 'scirrhous-type' and 'nonscirrhous-type' growth
107. Potential involvement of IL-10 in suppressing tumor-associated macrophages. Colon-26-derived prostaglandin E2 inhibits TNF-alpha release via a mechanism involving IL-10
108. Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin and 72-kDa gelatinase
109. Tumor angiogenesis: Past, present and the near future
110. The effects of insulin-like growth factors in tumorigenesis and neoplastic growth
111. N-Cadherin extracellular repeat 4 mediates epithelial to mesenchymal transition and increased motility
112. Cancer-susceptibility genes. Gatekeepers and caretakers
113. Landscaping the cancer terrain
114. Basement membrane patterns, gelatinase A and tissue inhibitor of metalloproteinase-2 expressions, and stromal fibrosis during the development of peripheral lung adenocarcinoma
115. Similar epithelial-stromal interactions in the regulation of hyaluronate production during limb morphogenesis and tumor invasion
116. Interactions between human tumor cells and fibroblasts stimulate hyaluronate synthesis
117. Activation of fibroblast-derived matrix metalloproteinase-2 by colon-cancer cells in non-contact co-cultures
118. Unraveling the role of proteases in cancer
119. Integrins alpha5beta1, alphavbeta1, and alphavbeta6 collaborate in squamous carcinoma cell spreading and migration on fibronectin
120. Plasminogen activators and plasminogen activator inhibitors in human colorectal carcinoma tissues are not expressed by the tumour cells
121. Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma
122. Stimulation of angiogenesis through cathepsin B inactivation of the tissue inhibitors of matrix metalloproteinases
123. Bradykinin stimulates lung fibroblasts to release neutrophil and monocyte chemotactic activity
124. TGF-beta1 secreted by gastric fibroblasts up-regulates CD44H expression and stimulates the peritoneal metastatic ability of scirrhous gastric cancer cells
125. Multicellular tumor spheroids: Intermediates between monolayer culture and in vivo tumor
126. Multicellular spheroids: A three-dimensional in vitro culture system to study tumour biology
127. A heterologous 3-D coculture model of breast tumor cells and fibroblasts to study tumor-associated fibroblast differentiation
128. Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: Clues to tumour-microenvironment interactions
129. Transforming growth factror-beta induction of type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase
130. Myofibroblast induction with transforming growth factor-beta1 and -beta3 in cutaneous fetal excisional wounds
131. Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue
132. Release of soluble ICAM-1 from human lung fibroblasts, aortic smooth muscle cells, dermal microvascular endothelial cells, bronchial epithelial cells, and keratinocytes
133. Epithelial cells are an important source of tenascin in normal and malignant human breast tissue
134. Localization and quantitation of hexabrachion (tenascin) in skin, embryonic brain, tumors, and plasma
135. Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38
136. Role of MCP-1 and RANTES in inflammation and progression to fibrosis during murine crescentic nephritis
137. RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis
138. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells
139. The significance of matrix metalloproteinases during early stages of tumor progression
140. Extracellular matrix in renal cell carcinomas
141. Basement membrane laminin-5 is deposited in colorectal adenomas and carcinomas and serves as a ligand for alpha3beta1 integrin
142. Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression
143. Tumor-associated hyaluronic acid: A new sensitive and specific urine marker for bladder cancer
144. Urinary hyaluronic acid and hyaluronidase: Markers for bladder cancer detection and evaluation of grade
145. Distribution of oncofetal fibronectin in human mammary tumors: Immunofluorescence study on histological sections
146. Salivary oncofoetal fibronectin and oral squamous cell carcinoma
147. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: Implications for tumor progression and clinical prognosis
148. Tenascin as a stromal marker for epithelial malignancy in the mammary gland
149. Cancer-associated changes in glycosylation of fibronectin. Immunohistological localization of oncofetal fibronectin defined by monoclonal antibodies
150. Oncofetal fibronectins in oral carcinomas: Correlation of two different types
151. The matrix metalloproteinase-9 regulates the insulin-like growth factor-triggered autocrine response in DU-145 carcinoma cells
152. Tumor-associated macrophages in neoplastic progression: A paradigm for the in vivo function of chemokines
153. The origin and function of tumor-associated macrophages
154. MMP-28, a new human matrix metalloproteinase with an unusual cysteine-switch sequence is widely expressed in tumors
155. Matrix metalloproteinases: Multifunctional contributors to tumor progression
156. Myofibroblasts
157. Myofibroblastic tumors. Brief review of clinical aspects, diagnosis and differential diagnosis
158. Identification of oncofetal fibronectin in patients with advanced epithelial ovarian cancer: Detection in ascitic fluid and localization or primary sites and metastatic implants
159. Human antibody derivatives against the fibroblast activation protein for tumor stroma targeting of carcinomas
160. Source of oncofetal ED-B-containing fibronectin: Implications of production by both tumor and endothelial cells
161. Comparative analysis of the expression of tenascin and established prognostic factors in human breast cancer
162. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: Implications for tumorigenesis
163. Three-dimensional cell cultures: From molecular mechanisms to clinical applications
164. The integrin alpha v beta 6 binds and activates latent TGF beta 1: A mechanism for regulating pulmonary inflammation and fibrosis
165. Proteolysis and cell migration: Creating a path?
166. Promotion of collagen production by human fibroblasts with gastric cancer cells in vitro
167. CD44: Structure, function, and association with the malignant process
168. Comparative analysis of the expression of the extracellular matrix protein tenascin in normal human fetal, adult and tumor tissues
169. Tumor and host molecules important in the organ preference of metastasis
170. Expression of tenascin and of the ED-B containing oncofetal fibronectin isoform in human cancer
171. Different mechanisms of extracellular matrix remodeling by fibroblasts in response to human mammary neoplastic cells
172. Role of matrix, fibroblasts and type IV collagenases in tumor progression and invasion
173. Progressive renal disease: Fibroblasts, extracellular matrix, and integrins
174. The latent transforming growth factor beta binding protein (LTBP) family
175. Identification of type I collagen-producing cells in human gastrointestinal carcinomas by non-radioactive in situ hybridization and immunoelectron microscopy
176. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas
177. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium
178. Evidence for tumor-host cooperation in regulating MMP-2 expression in human colon cancer
179. Involvement of platelet-derived growth factor in disease: Development of specific antagonists
180. Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta
181. Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression
182. Qualitative and quantitative changes of human tenascin expression in transformed lung fibroblast and lung tumor tissues: Comparison with fibronectin
183. GM-CSF, IL-1 alpha, IL-1 beta, IL-6, IL-8, IL-10, ICAM-1 and VCAM-1 gene expression and cytokine production in human duodenal fibroblasts stimulated with lipopolysaccharide, IL-1 alpha and TNF-alpha
184. The influence of the microenvironment on the malignant phenotype
185. Identification and characterization of human endometase (Matrix metalloproteinase-26) from endometrial tumor
186. Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts
187. Myofibroblast transformation of cat corneal endothelium by transforming growth factor-beta1, -beta2, and -beta3
188. TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells
189. Regulation of ICAM-1 expression and function in human dermal fibroblasts by IL-4
190. Expression of tenascin in human cervical cancer - Association of tenascin expression with clinicopathological parameters
191. Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia
192. Myofibroblasts I. Paracrine cells important in health and disease
193. Myofibroblasts II. Intestinal subepithelial myofibroblasts
194. Matrix metalloproteinase-2 activation in human hepatic fibrosis regulation by cell-matrix interactions
195. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas
196. Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization
197. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer
198. Induction of human tenascin (neuronectin) by growth factors and cytokines: Cell type-specific signals and signalling pathways
199. Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer
200. Expression and regulation of human pulmonary fibroblast-derived monocyte chemotactic peptide-1
201. Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia
202. A function for filamentous alpha-smooth muscle actin: Retardation of motility in fibroblasts
203. Identification, paracrine generation, and possible function of human breast carcinoma myofibroblasts in culture
204. The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells
205. Cellular changes involved in conversion of normal to malignant breast: Importance of the stromal reaction
206. Heparan sulphate proteoglycan expression in human primary liver tumours
207. Matrix metalloproteinases in remodeling of the normal and neoplastic mammary gland
208. CD44 and the adhesion of neoplastic cells
209. Fibronectin and its integrin receptors in cancer
210. Clinicopathologic significance of urokinase receptor- and MMP-9-positive stromal cells in human colorectal cancer: Functional multiplicity of matrix degradation on hematogenous metastasis
211. Tenascin induction in tenascin nonproducing carcinoma cell lines in vivo and by TGF-beta 1 in vitro
212. Differential regulation of metalloproteinase production, proliferation and chemotaxis of human lung fibroblasts by PDGF, interleukin-1 beta and TNF-alpha
213. Effect of heparin and related glycosaminoglycan on PDGF-induced lung fibroblast proliferation, chemotactic response and matrix metalloproteinases activity
214. Smoke extract stimulates lung fibroblasts to release neutrophil and monocyte chemotactic activities
215. Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts
216. Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family seletively expressed in stromal fibroblasts of epithelial cancers
217. Tenascin-C in serum: A questionnable tumor marker
218. Tumor-associated urokinase-type plasminogen activator: Biological and clinical significance
219. Phenotypic heterogeneity in breast ifbroblasts: Functional anomally in fibroblasts from histologically normal tissue adjacent to carcinoma
220. Fibroblast subpopulations as accelerators of tumor progression: The role of migration stimulating factor
221. Migration stimulating factor (MSF): Its structure, mode of action and possible function in health and disease
222. Substratum-dependent stimulation of fibroblast migration by the gelatin-binding domain of fibronectin
223. The myofibroblast in neoplasia
224. Myofibroblasts in the stroma of invasive and metastatic carcinoma: A possible host response to neoplasia
225. The myofibroblast: Biologic, pathologic, and theoretical considerations
226. Membrane-type matrix metalloproteinases
227. Mechanisms of myofibroblast activity and phenotypic modulation
228. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1
229. Human breast carcinoma desmoplasia is PDGF initiated
230. Immunohistochemical staining patterns of tenascin in invasive breast carcinomas
231. Tenascin staining positivity and the survival of patients with invasive breast carcinoma
232. Autocrine production of IL-10 mediates defective IL-12 production and NF-kappa B activation in tumor-associated macrophages
233. Cell-to-cell and cell-to-matrix interactions mediate chemokine expression: An important component of the inflammatory lesion
234. The normal structure and function of CD44 and its role in neoplasia
235. Discrimination of fibroblast subtypes of multivariate analysis of gene expression
236. Interferon-gamma and interleukin-4 differentially regulate ICAM-1 and VCAM-1 expression on human lung fibroblasts
237. Soluble IL-6 receptor induces calcium flux and selectively modulates chemokine expression in human dermal fibroblasts
238. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis
239. The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter
240. Synergistic induction of MCP-1 and -2 by IL-1beta and interferons in fibroblasts and epithelial cells
241. Prognostic significance of the size of central fibrosis in peripheral adenocarcinma of the lung
242. Tenascin-C modulates tumor stroma and monocyte/macrophage recruitment but not tumor growth or metastasis in a mouse strain with spontaneous mammary cancer
243. Collagen induced MMP-2 activation in human breast cancer
244. Know thy neighbor: Stromal cells can contribute oncogenic signals
245. Activation of matrix metalloproteinase-2 in head and neck squamous cell carcinoma: Studies of clinical samples and in vitro cell lines co-cultured with fibroblasts
246. Hyaluronectin blocks the stimulatory effect of hyaluronan-derived fragments on endothelial cells during angiogenesis in vitro
247. Inhibition of hyaluronan synthesis by vesnarinone in cultured human myofibroblasts
248. Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity
249. Pancreatic mucinous cystic neoplasms with sarcomatous stroma: Molecular evidence for monoclonal origin with subsequent divergence of the epithelial and sarcomatous components
250. Connective tissue as an active participant in the process of malignant growth
251. Stromal involvement in malignant growth
252. The N-cadherin/catenin complex in colon fibroblasts and myofibroblasts
253. Transforming growth factor-beta1 promotes the morphological and functional differentiation of the myofibroblast
254. Human MT6-matrix metalloproteinase: Identification, progelatinase A activation, and expression in brain tumors
255. Expression of 7F7-antigen, a human adhesion molecule identical to intercellular adhesion molecule-1 (ICAM-1) in human carcinomas and their stromal fibroblasts
256. Expression of tenascin during carcinogenesis and involution of hormone-dependent tissues
257. Concordance of genetic alterations in poorly differentiated colorectal neuroendocrine carcinomas and associated adenocarcinomas
258. Expression of tissue factor in tumor stroma correlates with progression to invasive human breast cancer: Paracrine regulation by carcinoma cell-derived members of the transforming growth factor beta family
259. Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: A different perspective in epithelial biology
260. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies
261. Role of the integrin alpha v beta 6 in cell attachment to fibronectin. Heterologous expression of intact and secreted forms of the receptor
262. New concepts in regulation and function of the insulin-like growth factors: Implications for understanding normal growth and neoplasia
263. The multiple roles of tumour stroma
264. Stromal expression of c-Ets1 transcription factor correlates with tumor invasion
265. Genetic alterations in the fibroblastic stroma of invasive colon and breast carcinomas
266. Activation of fibroblast collagenase-1 expression by tumor cells of squamous cell carcinomas is mediated p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase-2
267. Growth factors and epithelial-stromal interactions in prostate cancer development
268. Tenascin-C expression in prostatic intraepithelial neoplasia (PIN): A marker of progression?
269. Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 alpha loop
270. Fibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as "soil" for peritoneal dissemination
271. Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) CD106 (VCAM-1) up-regulation and IL-6 production and proliferation
272. Interferon-gamma inhibits by myofibroblastic phenotype of rat palatal fibroblasts induced by transforming growth factor-beta1 in vitro
273. Tenascin in breast cancer development - Is epithelial tenascin a marker for poor prognosis?
274. Role of the insulin-like growth factor family in cancer development and progression
275. Extracellular matrix proteins and VLA integrins expression in the microenvironment of human lung carcinoma
276. Tyrosine kinase signalling in breast cancer: Insulin-like growth factors and their receptors in breast cancer
277. Collagen-induced proMMP-2 activation by MT1-MMP in human dermal fibroblasts and the possible role of alpha2beta1 integrins